CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 120 enrolled
Drug / intervention
Benfotiamine +1 moredrug
Likely dose
Benfotiamine 600 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00680121
NCT00680121Phase 4Completed
CompareCT.gov

The Effectiveness of Benfotiamine in Reducing Abusive Drinking Among Family History Positive and Negative Alcoholics

University of Kansas·interventional·Posted May 19, 2008·Updated Sep 25, 2014

In Brief

A Phase 4 clinical trial evaluating Benfotiamine and Placebo for Alcoholism. Completed, enrolled 120 participants across 1 site.

Detailed Summary

B1AS tests the hypothesis that increased vitamin B1 (thiamine) intake can repair brain systems damaged by alcohol and help people with alcohol problems control their alcohol use. A strong, man-made form of thiamine (Benfotiamine) is used to increase blood thiamine to much higher levels than can be achieved using normal vitamin supplements. Drinking patterns are examined over 6 months of continued supplement use. Men and women with a recent history of alcohol problems are eligible to participate.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcoholism
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 19, 2008
Enrollment StartJul 1, 2008
Primary CompletionAug 1, 2011
Study CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 18.1 years ago

Interventions

Benfotiaminedrug

Benfotiamine 600 mg

Placebodrug

Placebo